MedPath

Pilot Trial: Bioavailability Animal vs. Plant Protein Drink

Not Applicable
Recruiting
Conditions
Nutrition, Healthy
Leucine Sensitivity
Interventions
Dietary Supplement: Consumption of protein - rich drink
Registration Number
NCT06465004
Lead Sponsor
ETH Zurich
Brief Summary

A pilot study is being conducted to compare a new plant-based protein drink to commercially available animal-based protein drinks. The goal is to assess if the plant-based drink delivers amino acids to the bloodstream as effectively as the animal-based drinks, potentially offering a viable option for those on plant-based diets.

The study will involve approximately 12 healthy adults aged 18-40. Each participant will try all three drinks (the new plant-based drink, a commercial animal-based drink, and another animal-based recipe) on separate days in a randomized order. Before and after (30, 60, and 90 minutes) consuming each drink, a small blood sample will be drawn to measure amino acid levels (leucine).

By comparing the results, the investigators hope to determine if the plant-based drink can match the effectiveness of animal-based protein drinks in delivering essential nutrients. This research could contribute to the development of sustainable and nutritious plant-based protein alternatives.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Plant-based AConsumption of protein - rich drinkA homemade drink containing plant-based proteins, formulated to have the same macronutrient content as the animal-based drinks.
Animal-based AConsumption of protein - rich drinkA commercially available high protein drink, based on animal proteins (Fresubin Protein Energy)
Animal-based BConsumption of protein - rich drinkA homemade drink containing animal-based proteins, using a specific animal-based protein isolate mix.
Primary Outcome Measures
NameTimeMethod
leucine content in the blood4 hours

Assessment of leucine content in blood before and 30-60-90 min after consumption of drink

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

SLA - ETH Zurich

🇨🇭

Schwerzenbach, Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath